# Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)

> **NCT07675109** · NA · RECRUITING · sponsor: **Noctrix Health, Inc.** · enrollment: 20 (estimated)

## Conditions studied

- Restless Legs Syndrome (RLS)

## Interventions

- **DEVICE:** Investigational Extended Duration (XD-) TOMAC Therapy
- **DEVICE:** Tonic Motor Activation (TOMAC) Therapy

## Key facts

- **NCT ID:** NCT07675109
- **Lead sponsor:** Noctrix Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-08
- **Primary completion:** 2026-12
- **Final completion:** 2027-06
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675109, "Optimizing Extended-Duration (XD-) TOMAC Therapy for Restless Legs Syndrome (RLS)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*